Tweet
Forbes (blog)
<img alt="" height="1" width="1" />
Regeneron: Data Confirm Drug's Success In Aiding Gout Treatment
Wall Street Journal
NEW YORK (Dow Jones)--Regeneron Pharmaceuticals Inc. (REGN) said Monday its drug Arcalyst was effective in reducing gout flares in patients that are beginning to use a standard therapy for the inflammatory ...
Regeneron's Gout Drug Meets Primary Endpoint In Phase-3 TrialRTT News
Regeneron's Arcalyst Treatment Shown to Help Prevent Gout Flares in StudyBloomberg
Regeneron scores big success with Ph3 Arcalyst gout dataFierceBiotech
Forbes (blog) -PR Newswire (press release)
all 29 news articles »
More...